Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial
Cephalalgia · 2024-05 · 44 (5)
DOI: 10.1177/03331024241248211 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cephalalgia, online erschienen am 10.05.2024. Verfasst von Lili Kokoti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: KATP Channels, Migraine Disorders. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lundbeck Foundation, Research Fund of Rigshospitalet, Lundbeck Foundation Professor Grant.
Abstract (Originalsprache)
Objective
To investigate the role of NN414, a selective K ATP channel opener for the Kir6.2/SUR1 channel subtype found in neurons and β-pancreatic cells, in inducing migraine attacks in individuals with migraine without aura.
Methods
Thirteen participants were randomly allocated to receive NN414 and placebo on two days separated by at least one week. The primary endpoint was the difference in the incidence of migraine attacks after NN414 compared with placebo. The secondary endpoints were the difference in the area under the curve for headache intensity scores, middle cerebral artery blood flow velocity (V MCA ), superficial temporal artery diameter, heart rate and mean arterial pressure.
Results
Twelve participants completed the study, with two (16.6%) reporting migraine attacks after NN414 compared to one (8.3%) after placebo (p = 0.53). The area under the curve for headache intensity, V MCA , superficial temporal artery diameter, heart rate and mean arterial pressure did not differ between NN414 and placebo (p > 0.05, all comparisons).
Conclusion
The lack of migraine induction upon activation of the Kir6.2/SUR1 channel subtype suggests it may not contribute to migraine pathogenesis. Our findings point to K ATP channel blockers that target the Kir6.1/SUR2B subtype, found in cerebral vasculature, as potential candidates for innovative antimigraine treatments. Registration number: NCT04744129
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Danish Headache Knowledge Center, Rigshospitalet - Glostrup, Glostrup, Denmark.
ORCID-Profile: Lili Kokoti, Mohammad Al-Mahdi Al-Karagholi
Förderung
- Lundbeck Foundation
- Research Fund of Rigshospitalet
- Lundbeck Foundation Professor Grant
Zitieren
APA
Kokoti, L., Al-Karagholi, M. A., Zhuang, Z. A., Amirguliyev, S., Amin, F. M., & Ashina, M. (2024). Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial. Cephalalgia, 44(5). https://doi.org/10.1177/03331024241248211
Vancouver
Kokoti L, Al-Karagholi MA, Zhuang ZA, Amirguliyev S, Amin FM, Ashina M. Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial. Cephalalgia. 2024;44(5). doi:10.1177/03331024241248211
BibTeX
@article{Kokoti2024,
author = {Kokoti, Lili and Al-Karagholi, Mohammad Al-Mahdi and Zhuang, Zixuan Alice and Amirguliyev, Sarkhan and Amin, Faisal Mohammad and Ashina, Messoud},
title = {Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial},
journal = {Cephalalgia},
year = {2024},
volume = {44},
number = {5},
doi = {10.1177/03331024241248211}
}
EUVIMED